Lakeshore Biopharma Co. Ltd.
13F holders, Q1 2024 (March 31)9holders
$0.71avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings. The largest holders were Orbimed Advisors LLC ($1.1M), FIL Ltd ($843K) and FMR LLC ($816K).
- Company
- Lakeshore Biopharma Co. Ltd.
- Filed as
- YS BIOPHARMA CO LTD (Q1 2024)
- CUSIP
- G9845F109
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $275K |
| Exits | 3 | $844K |
Ownership 9 holders
| Orbimed Advisors LLC | 0.02% | Reduce -52.6% | 1,534,430 | $1.1M |
| FIL Ltd | 0.00% | Reduce -45.3% | 1,204,763 | $843K |
| FMR LLC | 0.00% | No change | 1,165,071 | $816K |
| HHLR Advisors, LTD. | 0.01% | No change | 751,790 | $526K |
| Bank of Montreal | 0.00% | New | 344,120 | $275K |
| Superstring Capital Management LP | 0.14% | No change | 307,920 | $216K |
| Geode Capital Management, LLC | 0.00% | No change | 13,608 | $10K |
| Pinpoint Asset Management Ltd | 0.00% | No change | 50,000 | $4K |
| Wolverine Asset Management LLC | 0.00% | No change | 499 | $359 |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.